Daiichi Sankyo (Portugal)
Portuguese affiliate of the global pharmaceutical company Daiichi Sankyo, based in Porto Salvo.
Last updated September 15, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Daiichi Sankyo (Portugal) is the Portuguese presence of Daiichi Sankyo, described on its website as a global pharmaceutical company headquartered in Japan and present in more than 20 countries worldwide. Its Portuguese site presents the company's patient-centric commitment, its DSPACE digital solutions initiative complementing the cardiovascular and oncology portfolio, and links to European news and careers. Wikidata records it as a company in Porto Salvo, Portugal.
History
The Portuguese website of Daiichi Sankyo states that Daiichi Sankyo is a global pharmaceutical company headquartered in Japan and present in more than 20 countries worldwide. It also describes the company's history in Europe as dating back to 1980, when both Daiichi and Sankyo established themselves in Düsseldorf, Germany; in 1990 Sankyo acquired the German mid-sized pharmaceutical company Luitpold-Werk; and in 2006 the merger of the two historic Japanese companies was completed. Today the European headquarters is in Munich, Germany, and the company operates in 13 European countries and Canada. The Portuguese site presents DSPACE, described as complementing the Daiichi Sankyo portfolio in the cardiovascular and oncology areas, and a patient-centricity commitment under the motto 'Paixão pela Inovação. Compaixão pelos Doentes.' Wikidata records Daiichi Sankyo (Portugal) as a company in Porto Salvo, Portugal.
Products and positioning
Patient-centric pharmaceutical company focused on therapeutic innovation; DSPACE positions it as an innovative healthcare company contributing to sustainable societal development.
Sources5 sources
Cite this profile: Cite the canonical profile. /brand-wiki/daiichi-sankyo-portugal · Editorial policy · How profiles are compiled